Editor's Correspondence |

A Different Perspective Regarding Prostate-Specific Antigen Testing

Paul Ross Casner, MD, PhD
Arch Intern Med. 2012;172(14):1110-1114. doi:10.1001/archinternmed.2012.2038.
Text Size: A A A
Published online


I wish to provide a different perspective regarding prostate-specific antigen (PSA) testing and prostate cancer to the one reported by Dr Bennet.1 I was diagnosed as having prostate cancer at a similar age to Dr Bennet (57 years) some 6 years ago. I had routinely checked my PSA on a yearly basis, and it was typically around 2.0 ng/mL (to convert to micrograms per liter, multiply by 1). When retested it went up to 3.3 ng/mL, an unusual increase compared with my previous values but still within what was considered the “normal range.” Despite that, I was concerned about the sudden increase. I had symptoms of benign prostatic hyperplasia, and my father had prostate cancer in his mid 70s. I decided to consult a urologist colleague. On examination, my prostate was slightly asymmetric but without nodules. My urologist told me it was very unlikely to have prostate cancer but recommended a biopsy because of my family history. One of 10 biopsy specimens was reported positive for prostate cancer, with a Gleason score of 6 (3 + 3).

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





July 23, 2012
Deborah Grady, MD, MPH; Rita F. Redberg, MD, MSc
Arch Intern Med. 2012;172(14):1110-1114. doi:10.1001/archinternmed.2012.2637.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles